AMBROXOL 15MG TERBUTALINE 1.25MG GUAIPHENESIN 50MG MENTHOL 2.5MG SYRUP is a combination of four active ingredients in a single formulation in the form of an oral liquid, Present in four different concentrations and is an oral solution. Multicomponent mixtures like ambroxol, terbutaline, guaiphenesin and menthol, in an oral liquid formulation, comprise four different concentrations and require a liquid vehicle that is well balanced to maintain the required concentration, look, smell, mixability and texture of product consistently throughout the shelf life. Since the four components of a liquid form have different physical and chemical properties, solubilization, dispersion, flavour and analysis need to be calibrated.
The formulation also includes four ingredients, each of which are present at different concentrations than the other ingredients. Ambroxol and guaiphenesin are present at higher concentrations, whereas menthol and terbutaline are present at lower concentrations. As such, appropriate dispensing and addition is critical.
For all authorised formulations, the vehicle may consist of purified water, sweetener(s), viscosity-inducing agent(s), flavor components, solubilizer(s), preservative(s) when appropriate, and other pharmaceutic excipients. The excipient system is adapted to the approved formulation and the physical nature of each excipient.
On the other hand, solubility and compatibility studies can be conducted during development in order to establish the interaction of the ingredients within the liquid vehicle. We aim to achieve a homogenous product with no formation of sediment, crystallization or phase separation on storage.
Ingredient addition sequence Single component syrup quality can be adversely affected by the sequence in which the ingredients are added. Some ingredients with various solubility characteristics may need to be pre-dissolved in order to add them to the main vehicle.
Ambroxol, terbutaline, and guaiphenesin can be incorporated as per formulation history, whereas Menthol may need an equivalent solubilizer depending on its uniqueness. Even premixing can be aimed at before incorporation or an ideal solubilizer may be considered.
Prior to addition of active components, the bulk vehicle may be coated with a blend of selected soluble excipients. Each API is subsequently introduced and blended under specified batch conditions according to the fully validated manufacturing process. Time, speed, temperature and addition rates are recorded for reproducibility.
Subsequently, the solution can be filtered for clarity or even dispersion (if plan of action involves batching).
The viscosity of the syrup is a critical quality attribute as it influences filling, pouring, dispensing, and overall workability of the product. Viscosity modifiers can be added to attain the desired rheology without impacting the stability of the active constituents.
Mixing several active ingredients together can alter both taste and odour. The dectective taste of menthol provides an identifying property. Other ingredients within the formulation can also require an appropriate balancing flavour and hence in formulation they are accompanied by sweetening and flavouring systems.
PH Another critical parameter is the pH because the pH can affect the stability and solubility of certain ingredients. The final pH is determined by a formulation-development and stability studies.
The finished syrup should not show any signs of unacceptable precipitation, crystallisation or colour change for the period of intended storage.
Steps in Manufacturing The manufacturing process begins with the weighing, and sign-off, of each active ingredient and excipient. Dispensing is especially critical as the four active components are present at different levels.
Examples of in-process checks are the appearance of the bulk, pH, viscosity, temperature, mixing status, and homogeneity. If the formulation has any dispersed phase, more checks may be necessary to ascertain the uniformity of distribution.
Finished-product testing may encompass ID and assay of active ingredients, pH, viscosity, microbial quality, where relevant, specific gravity, fill volume, appearance, etc. in accordance with the specifications for the product.
The methods should be capable of for accurately differentiating and measuring ambroxol, terbutaline, guaiphenesin and menthol in each formulation. Suitable sample preparation and validated analytical methods aid in supporting the batch-release decisions.
Stability testing aims to establish whether AMBROXOL 15MG TERBUTALINE 1.25MG GUAIPHENESIN 50MG MENTHOL 2.5MG SYRUP will retain the required quality during the shelf life as claimed. Tests may be carried out to determine assay, degrada, on products, pH, visi, es, appearance, colour, odour, micro-bio-qual-ity, etc.
Packaging compatibility is another concern since the liquid formulation is in contact with the primary container during storage. The compatibility and stability considerations of the formulation should be used to determine if pharmaceutical grade plastic or glass bottles are appropriate.
The closure system should be able to prevent leaks and ingress of foreign material. Fill-volume accuracy, seal integrity, container-closure interaction and product recovery may be evaluated during packaging development.
If appropriate, exposure to light and temperature should be part of the stability studies for the finished formulation.
AMBROXOL 15MG TERBUTALINE 1.25MG GUAIPHENESIN 50MG MENTHOL 2.5MG SYRUP involve a co-ordinated control of raw-material dispensation, solubilising, liquid blending, viscosity adjusting, flavouring, analytical testing, stability testing and packaging. Since each of the four actives are supplied at different strength levels, process consistency is of prime importance.
Pharmaceuticals for Pharma Companies The multiple component formula can be designed as part of a PCD Pharma Franchise range of products when regulatory obligations, manufacturing best practices and suitable quality documentation are in place. This physicochemical characteristic, the deliberate addition of ingredients, strong analytical testing, stable physical form, packaging, and existing stability studies provide the necessary foundation.
Ambroxol + Terbutaline + Guaiphenesin + Menthol Syrup with formulation, manufacturing and quality details.
We combine quality, innovation, and strong distribution to help our partners grow successfully in the pharma market.
The company is offering business opportunity for scalable and sustainable returns to its associates. We are engaged in discovery, development and commercialization of pharmaceutical medicine keeping in mind its quality and affordability.
© Novolilly 2025. All Rights Reserved – Developed & Managed By Kavir Infotech